RecruitingPhase 3NCT06337292

Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures

Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures: A Multicenter Randomized Controlled Trial


Sponsor

Major Extremity Trauma Research Consortium

Enrollment

352 participants

Start Date

Jan 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This is a multi-center, pragmatic, parallel arm randomized controlled trial (RCT) of 352 patients with high-risk open or closed tibial plateau fracture, high-risk open or closed tibial pilon fracture, or open tibial shaft fracture with incision \>3cm. Eligible participants will be randomized to receive either incisional negative pressure wound therapy (NPWT) or a non-suction standard-of-care wound dressing for their definitive wound management. The primary outcome will be a composite outcome to evaluate clinical status 3 months after randomization. The secondary outcomes will independently assess the components of the primary outcome.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • All open or closed tibial plateau or pilon fractures treated operatively with internal fixation at high risk for complication. Any open Gustilo Type I, II or IIIA tibial shaft fracture treated definitively with internal or external fixation with or without ipsilateral leg compartment syndrome if at least one wound is primarily closed.
  • We define high-risk fractures as those that are either:
  • Closed fracture initially treated with an external fixator (with or without limited internal fixation) and treated definitive more than 3 days later after swelling has resolved;
  • Any open type I, II or IIIA fracture, regardless of timing of definitive treatment;
  • Any tibial plateau fracture associated with ipsilateral leg compartment syndrome fasciotomy wounds that has at least one wound primarily closed
  • Requiring incision for fixation or debridement of 3 cm or greater.
  • Patients 18 years of age or older

Exclusion Criteria5

  • The study injury is already infected at time of study enrollment.
  • Patient is unable to receive incisional NPWT for any reason.
  • Patients who have already had definitive fixation prior to enrollment in the study.
  • Severe problems with maintaining follow-up (e.g., patients who are homeless at the time of injury or those who are intellectually challenged without adequate family support or who are prisoners).
  • The study injury is a Gustilo Type IIIB or IIIC open fracture.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEIncisional Negative Pressure Wound Therapy (NPWT)

Participants in the treatment group will be standardized and will receive incisional NPWT using the any incisional VAC system that can apply 75-125mmHg continuous suction to the incision. The VAC sponge will be placed over the surgical wound at least 2cm in width and \>3cm in length.


Locations(2)

University of Maryland R Adams Cowley Shock Trauma Center

Baltimore, Maryland, United States

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06337292


Related Trials